SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-006821
Filing Date
2018-02-09
Accepted
2018-02-09 11:48:13
Documents
24
Period of Report
2018-02-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv485405_8k.htm 8-K 15944
2 EXHIBIT 99.1 tv485405_ex99-1.htm EX-99.1 30722
3 GRAPHIC image_001.jpg GRAPHIC 54996
4 GRAPHIC image_002.jpg GRAPHIC 83932
5 GRAPHIC image_003.jpg GRAPHIC 93994
6 GRAPHIC image_004.jpg GRAPHIC 103756
7 GRAPHIC image_005.jpg GRAPHIC 107681
8 GRAPHIC image_006.jpg GRAPHIC 117268
9 GRAPHIC image_007.jpg GRAPHIC 75435
10 GRAPHIC image_008.jpg GRAPHIC 101600
11 GRAPHIC image_009.jpg GRAPHIC 98053
12 GRAPHIC image_010.jpg GRAPHIC 93352
13 GRAPHIC image_011.jpg GRAPHIC 84035
14 GRAPHIC image_012.jpg GRAPHIC 57583
15 GRAPHIC image_013.jpg GRAPHIC 65610
16 GRAPHIC image_014.jpg GRAPHIC 58744
17 GRAPHIC image_015.jpg GRAPHIC 68759
18 GRAPHIC image_016.jpg GRAPHIC 69636
19 GRAPHIC image_017.jpg GRAPHIC 59752
20 GRAPHIC image_018.jpg GRAPHIC 49873
21 GRAPHIC image_019.jpg GRAPHIC 52312
22 GRAPHIC image_020.jpg GRAPHIC 89996
23 GRAPHIC image_021.jpg GRAPHIC 81126
24 GRAPHIC image_022.jpg GRAPHIC 86683
  Complete submission text file 0001144204-18-006821.txt   2465301
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 18589765
SIC: 2834 Pharmaceutical Preparations